Europe Amniotic Membrane Market is expected to grow with the CAGR of 8.1% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-amniotic-membrane-market

Europe amniotic membrane market is a highly consolidated market. The market has witnessed increased strategic developments owing to favorable market scenario.

The major players dealing in Europe amniotic membrane market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

• In September 2021,  Amnio Technology, LLC announced that United States Patent and Trademark Office issued a new patent to the company, titled “Enriched Multilayered Amnion Derived Tissue Graft. This has helped the company to strengthen its intellectual property position by protecting its advanced allograft manufacturing process in U.S.

Organogenesis, Inc. is dominating player in Europe amniotic membrane market. The other key players existing in the market includes Smith & Nephew plc, Stryker, Katena Products. Inc., The Electrospinning Company, NuVision Biotherapies Ltd, Amnio Technology, LLC, Integra LifeSciences, MIMEDX, Applied Biologics, SKYE BIOLOGICS HOLDINGS, LLC and Amniox Medical, Inc.

Organogenesis, Inc.

Organogenesis, Inc. was founded in 1985 and is headquartered in Massachusetts, U.S. The company is focused in empowering healing through the development, manufacturing and sale of products for the advanced wound care, and surgical and sports medicine markets. The various segments of the company include Advanced Wound Care, Surgical & Sports Medicine and the market focused segment is Advanced Wound Care. The company offers range of product categories including Affinity, NUShield, Apligraf, Dermagraft, FiberOS, FiberOS Neos, OCMP, PuraPlyAM in which market focused category fall under Affinity.

For instance,

• In October 2021, Organogenesis Showcase Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference. Company announced that the latest advanced wound care research on PuraPly AM, Affinity, Apligraf, and NuShield product lines will be showcased at the 2021 Symposium on Advanced Wound Care (SAWC). This has helped company to improve its position in market

The company has global presence in U.S. The company has many subsidiaries such as NuTech Medical (U.S.) and Organogenesis Inc. (U.S.).

MIMEDX

MIMEDX was founded in 2008 and is headquartered in Marietta, Georgia. The company focuses on advanced wound care and therapeutic biologics. The company has single business segment: Regenerative Biomaterials. The company offers range of product categories including Advanced Wound Solutions, Advanced Surgical Solutions in which market focused category falls under Advanced Wound Solutions.

For instance,

• In March 2021, MiMedx awarded Amniotic Tissue Supplier Agreement with Premier Inc. SURPASS Purchasing Program. The company has been awarded a Group Purchasing Agreement for its amniotic tissue portfolio with Premier Inc.’s Synergizing for Unparalleled Results in Procurement and Strategic Sourcing (SURPASS) purchasing program. This has helped company to improve its position in market

The company has global presence in Georgia. The company has many subsidiaries such as Surgical Biologics, LLC (U.S.) and Hayfin Services, LLP(U.K.)

Smith & Nephew, plc

Smith & Nephew, plc was founded in 1856 and is headquartered in Herefordshire, U.K. The company is focused in providing a comprehensive set of medical products to meet broad and complex clinical needs and to help healthcare professional. The various segments of the company include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management in which market focused segment is Advanced Wound Management. The company offers product categories including Advanced Wound Management, Orthopedic Reconstruction, Real Intelligence, Sports Medicine, Trauma & Extremities, Ear, Nose and Throat, Material Composition in which the market focused category falls under Advanced Wound Management.

For instance

• In March 2019, Smith & Nephew plc announced that it has acquired Osiris Therapeutics, Inc., a company engaged in delivering regerative medicine products. This stratergic decision has helped the company to enahcance its wound management product portfolio

The company has global presence in the North America, Europe, Asia-Pacific, South America, Middle East and Africa. The company has many subsidiaries such as A2 Surgical (France), Blue Sky Medical Group Inc (U.S.), Endocare GmbH (Germany), Exogen, Inc (U.S.), Healicoil Inc. (U.S.) among others.